Literature DB >> 16048945

Relationship between in vitro activities of amphotericin B and flucytosine and pH for clinical yeast and mold isolates.

D T A te Dorsthorst1, P E Verweij, J F G M Meis, J W Mouton.   

Abstract

In this study, we investigated the pH dependency of the in vitro activities of amphotericin B (AMB) and flucytosine (5FC) against Candida spp., Cryptococcus neoformans, Aspergillus fumigatus, Rhizopus spp., and Scedosporium prolificans in RPMI 1640 buffered with citrate buffer (pH 4.0, 5.0, 5.4, and 6.0), citrate-phosphate buffer (pH 5.4, 6.0, 6.4, and 7.0), and 3-[N-morpholino]propanesulfonic acid (MOPS) (pH 6.4, 7.0, 7.4, and 7.9). For 5FC, no significant differences were found between MICs obtained with the different buffers, while for AMB, significant differences were found. The MICs obtained with citrate-phosphate buffer were approximately 1 twofold-dilution step higher than the MICs obtained with MOPS. We demonstrated that the in vitro activities of AMB and 5FC against yeast and mold isolates were pH dependent. The in vitro activity of AMB decreased when the pH was lowered, while the in vitro activity of 5FC increased. The effect of the pH on the in vitro activities was dependent not only on the antifungal agent tested but also on the microorganism. For AMB, there was a nonlinear relationship (median r(2), 0.864) for Candida spp., C. neoformans, A. fumigatus, and Rhizopus spp. over the pH range tested. The mean MICs ranged from 0.5 to 2.52 microg/ml at pH 7.0 and from 20.16 to 32 microg/ml at pH 5.0. For S. prolificans, there was no relationship. For 5FC, there was a linear relationship for Candida spp. (median r(2), 0.767) and a nonlinear relationship for C. neoformans and A. fumigatus (median r(2), 0.882) over the pH range tested. The mean MIC values ranged from 0.125 to 1,024 microg/ml at pH 7.0 and from 0.02 to 4 microg/ml at pH 5.0. For Rhizopus spp. and S. prolificans, the relationship could not be determined, since the MIC was >1,024 microg/ml over a pH range of 4.0 to 7.9.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16048945      PMCID: PMC1196209          DOI: 10.1128/AAC.49.8.3341-3346.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

Review 1.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates.

Authors:  D T A Te Dorsthorst; J W Mouton; C J P van den Beukel; H A L van der Lee; J F G M Meis; P E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

3.  Bacterial concentrations in pus and infected peritoneal fluid--implications for bactericidal activity of antibiotics.

Authors:  C König; H P Simmen; J Blaser
Journal:  J Antimicrob Chemother       Date:  1998-08       Impact factor: 5.790

4.  Establishment of an experimental model of a Staphylococcus aureus abscess in mice by use of dextran and gelatin microcarriers.

Authors:  C W Ford; J C Hamel; D Stapert; R J Yancey
Journal:  J Med Microbiol       Date:  1989-04       Impact factor: 2.472

5.  Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species.

Authors:  J Meletiadis; J W Mouton; J F Meis; B A Bouman; P J Donnelly; P E Verweij
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

6.  Antibodies against Aspergillus fumigatus. I. Standardization of the antigenic composition.

Authors:  H F Kauffman; K de Vries
Journal:  Int Arch Allergy Appl Immunol       Date:  1980

7.  Analysis of pH and pO2 in abscesses, peritoneal fluid, and drainage fluid in the presence or absence of bacterial infection during and after abdominal surgery.

Authors:  H P Simmen; J Blaser
Journal:  Am J Surg       Date:  1993-07       Impact factor: 2.565

8.  beta-Lactamase activity in human pus.

Authors:  R E Bryant; A L Rashad; J A Mazza; D Hammond
Journal:  J Infect Dis       Date:  1980-10       Impact factor: 5.226

9.  Flucytosine and cryptococcosis: which in vitro test is the best predictor of outcome?

Authors:  M A Viviani; M C Esposto; M Cogliati; A M Tortorano
Journal:  J Chemother       Date:  2003-04       Impact factor: 1.714

10.  The peritoneal environment during infection. The effect of monomicrobial and polymicrobial bacteria on pO2 and pH.

Authors:  R G Sawyer; M D Spengler; R B Adams; T L Pruett
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

View more
  10 in total

1.  Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis.

Authors:  E Dannaoui; M Abdul; M Arpin; A Michel-Nguyen; M A Piens; A Favel; O Lortholary; F Dromer
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

2.  Efficacy and pharmacodynamics of flucytosine monotherapy in a nonneutropenic murine model of invasive aspergillosis.

Authors:  D T A te Dorsthorst; P E Verweij; J F G M Meis; J W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  Comparison of MIC Test Strip and Sensititre YeastOne with the CLSI and EUCAST Broth Microdilution Reference Methods for In Vitro Antifungal Susceptibility Testing of Cryptococcus neoformans.

Authors:  Fatima Zohra Delma; Abdullah M S Al-Hatmi; Jochem B Buil; Hein van der Lee; Marlou Tehupeiory-Kooreman; G Sybren de Hoog; Joseph Meletiadis; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

4.  Cryptic species and azole resistance in the Aspergillus niger complex.

Authors:  Susan J Howard; Elizabeth Harrison; Paul Bowyer; Janos Varga; David W Denning
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

5.  [Candiduria! What now? : Therapy of urinary tract infections with Candida].

Authors:  H Hof
Journal:  Urologe A       Date:  2017-02       Impact factor: 0.639

6.  Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effect.

Authors:  William W Hope; Peter A Warn; Andrew Sharp; Susan Howard; Miki Kasai; Arnold Louie; Thomas J Walsh; George L Drusano; David W Denning
Journal:  Antimicrob Agents Chemother       Date:  2006-09-05       Impact factor: 5.191

7.  Mechanistic Basis of pH-Dependent 5-Flucytosine Resistance in Aspergillus fumigatus.

Authors:  Fabio Gsaller; Takanori Furukawa; Paul D Carr; Bharat Rash; Christoph Jöchl; Margherita Bertuzzi; Elaine M Bignell; Michael J Bromley
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

8.  Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis.

Authors:  Omar J M Hamza; Mecky I N Matee; Mainen J Moshi; Elison N M Simon; Ferdinand Mugusi; Frans H M Mikx; Wim H van Palenstein Helderman; Antonius J M M Rijs; André J A M van der Ven; Paul E Verweij
Journal:  BMC Microbiol       Date:  2008-08-12       Impact factor: 3.605

9.  The microbial diversity of traditional spontaneously fermented lambic beer.

Authors:  Freek Spitaels; Anneleen D Wieme; Maarten Janssens; Maarten Aerts; Heide-Marie Daniel; Anita Van Landschoot; Luc De Vuyst; Peter Vandamme
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

10.  Multiplex Genetic Engineering Exploiting Pyrimidine Salvage Pathway-Based Endogenous Counterselectable Markers.

Authors:  Lukas Birštonas; Alex Dallemulle; Manuel S López-Berges; Ilse D Jacobsen; Martin Offterdinger; Beate Abt; Maria Straßburger; Ingo Bauer; Oliver Schmidt; Bettina Sarg; Herbert Lindner; Hubertus Haas; Fabio Gsaller
Journal:  mBio       Date:  2020-04-07       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.